Participants 73 110 3
for steroid-dependent Crohn's disease
Participants 178 269 6
More than 50% of patients with Crohn's disease become either steroid resistant or dependent
Participants 518 602 9
Patients with steroid-dependent Crohn's disease (n = 271) were enrolled in a 36-week
Participants 1083 1164 3
The primary efficacy endpoint was the percentage of patients with steroid sparing
Participants 1509 1603 5
CDP571 was ineffective for sparing steroids in patients with steroid-dependent Crohn's disease
